ASCCP 2021 Virtual Scientific Meeting on Anogenital & HPV-Related Diseases - Starting in April 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ASCCP 2021 Virtual Scientific Meeting
on Anogenital & HPV-Related Diseases
Starting in April 2021
Early Bird Registration Ends January 31
Improving Lives Through the Prevention & Treatment
of Anogenital & HPV-Related Diseases
About the Meeting The ASCCP 2021 Virtual Scientific Meeting on Anogenital & HPV-Related Diseases is an interdisciplinary meeting that brings together healthcare professionals in the areas of obstetrics and gynecology, family medicine, oncology, pathology, internal medicine, and dermatology, as well as industry representatives. Offering a combination of live sessions and on-demand recordings, this meeting will give attendees flexibility in accessing exciting content, including, but not limited to, the 2019 ASCCP Risk-Based Management Consensus Guidelines, racial disparities in outcomes and screening in cervical/head/neck cancer, microbiome and HPV clearance, new technologies, and HPV testing and vaccine. Program Chairs Co-Chair Co-Chair Assistant Co-Chair Levi S. Downs, Jr., Akiva P. Novetsky, Patty Cason, MD, MS MD, MS MS, FNP-BC Park Nicollet Rutgers - New Jersey Envision Sexual and Health Services Medical School Reproductive Health Minneapolis, MN Newark, NJ Los Angeles, CA
Expand Your Knowledge Through Pre-Courses!
The following pre-courses will be available on-demand and can be viewed
at your convenience for up to 6 months following the meeting. Take one or
both. Separate registration fees are required.
Advanced Discussions in Vulvovaginal Diseases
The Advanced Discussions in Vulvovaginal Diseases course is designed to
provide an up-to-date review of vulvovaginal conditions and will discuss
questions regarding a variety of common presenting conditions.
Presentations will cover vaginitis with a focus on noninfectious and
persistent, the “itchy” vulva, atrophy and vulvodynia, as well as vulvar
procedures tips and tricks.
Course Level: Intermediate to Advanced
Speakers:
Colleen K. Stockdale, MD, MS, Course Director; Hope K. Haefner, MD;
Kathryn C. Welch, MD; and Cynthia A. Rasmussen, MD
Screening for Anal Disease
This course is for providers with experience in colposcopy of the female
genital tract who may have background in high-resolution anoscopy
through a previous course or are in practice. This course is designed to
provide a current and comprehensive review including a discussion of
cases (presentation, diagnosis, and management) regarding common
presenting complaints.
Course Level: Advanced
Speakers:
Lisa Flowers, MD, MPH, Course Director; Naomi Jay, PhD, NP, RN; Michelle J.
Khan, MD, MPH; and Joel M. Palefsky, MD
Registration Fee: $275.00 per Pre-Course
Program Highlights
Keynote Lecture
Pap Smear to Papillomavirus: The Conquest of
Cervical Cancer
Robert D. Burk, MD
Professor and Vice Chair, Translational Research, Pediatrics,
Professor, Microbiology and Immunology,
Professor, Epidemiology and Population Health, Albert
Einstein College of Medicine
Attending Physician, Pediatrics, Children’s Hospital
at Montefiore
Dr. Burk will discuss our progress towards prevention of cervical cancer as
one of modern medicine’s great accomplishments. This presentation will
highlight the evidence bringing us from the early days of pap smears to the
extraordinary contribution of human papillomavirus (HPV) testing and the
increasing significance of HPV types.
More About Dr. Burk
Dr. Burk received his MD from the George Washington University School of Medicine and completed
surgical internship at UCSF followed by a residency in pediatrics at UCSF. He then completed a medical
genetics fellowship at Johns Hopkins. He is board certified in both pediatrics and medical genetics. His
research interests include the natural history of cervical human papillomavirus (HPV), papillomavirus
genomics, and understanding HPV variation and human disease. He has published over 450 papers in
peer-reviewed journals.
Dr. Burk has been a member of the Papillomavirus Study Group of the International Committee on
Taxonomy of Viruses (ICTV) for over 20 years and was the past chair of the group. He is a member of the
executive board of the International Papillomavirus Society (IPVS). He has been consistently funded by
NIH for over 30 years and is an elected Fellow of the AAAS.
Program
Plenary #1: Racial Disparities High-Level Methods with
Moderator: Levi S. Downs, Jr., Description of Risk Thresholds,
MD, MS Didem Egemen, PhD
Implicit Bias, Levi S. Downs, Updates on Head and Neck
Jr. , MD, MS Cancer Epidemiology
Racial Disparities in Cervical Moderator: Gypsyamber D’Souza,
Screening & Cervical Cancer, PhD, MPH
Michelle J. Khan, MD, MPH Will Screening Play a Role in
Racial Disparities in Head Management of H&N Disease?,
and Neck, Gypsyamber D’Souza, Eleni Marie Rettig, MD
PhD, MPH Risk Factors for HNC and
Gender Consideration. Effect of
2019 Guidelines Sexual Behavior, Tobacco, etc.,
Moderator: Didem Egemen, PhD Differences by Sex and
Implications, Anna R. Giuliano,
Guidelines Summary and PhD
FAQs Over the Past Year of Risk Prediction of HNC
Implementation, Rebecca B. Survival, Carol Fakhry, MD, MPH
Perkins, MD, MSc & Richard S.
Guido, MD
Opportunities and Obstacles
of the New Guidelines in Clinical Includes live and
Implementation, Rebecca B.
Perkins, MD, MSc & Richard S. on-demand sessions
Guido, MD
www.asccp.org/2021meeting
Plenary #2: Keynote Microbiome and HPV
Clearance
Keynote: Pap Smear to Moderator: Anna-Barbara
Papillomavirus: The Conquest Moscicki, MD
of Cervical Cancer, Robert D. Microbiome and
Burk, MD Inflammation in HPV and CIN 2
Clearance, Anna-Barbara
Spotlight on New Moscicki, MD
Technologies
Cervicovaginal Microbiome,
Moderator: Mark H. Einstein,
Inflammation and HPV Natural
MD, MSc
History, Robert D. Burk, MD
Enduring Guidelines: Anal Microbiome and
Incorporating New Technologies HPV-Associated Anal Disease,
into Screening and Management Joel M. Palefsky, MD
Guidelines, Nicolas Wentzensen,
The Role of the Cervicovaginal
MD, PhD
and Gut Microbiome in HPV
p16/Ki-67 Dual Stain in Gynecologic Malignancies, Travis T.
Screening and Management, Sims, MD, MPH
Megan A. Clarke, PhD, MHS
Plenary #3: Primary HPV
HPV Genotyping in Screening Testing
and Management, Moderator: Philip E. Castle, PhD,
Elizabeth R. Unger, MD, PhD MPH
Human Papillomavirus (HPV)
Testing With and Without
Abstracts will also Cytology Co-Testing: Is the Juice
be presented Worth the Squeeze?, Philip E.
Castle, PhD, MPH
New Acquisition and Viral
Reactivation: HPV Natural History
Through the Lifespan, Rachel L.
Winer, PhD, MPH
Cervical Cancer and HPV by
Age. Where Do We Stand on Risk
at Older Ages?, Anne F. Rositch,
PhD, MSPH
Overview of Screening
Performance and Screening
History Assessment in
Postmenopausal Exiting Decisions,
Implementation in the U.S.— Michelle I. Silver, PhD
Barriers and Strategies, Walter K.
Kinney, MD Clinical Management and
The Challenges of the Counseling of Menopausal Women
Diffusion of New Technologies to in HPV Screening Programs, Anne
All Populations: The Case of HPV Hammer, MD, PhD
Testing, Electra D. Paskett, PhD
Significance and Differential
Self Collection for Primary HPV Diagnosis of New HPV Detection,
Screening, Mark S. Schiffman, Maria DeMarco, PhD, MPH
MD, MPH
Plenary #4: HPV Ecology and
Cervical Cancer Screening in Content will be
Post-Menopausal Women available for 6 months
Moderator: Patti E. Gravitt, PhD, MS
www.asccp.org/2021meeting
Plenary #5: New Frontiers for Therapeutic Vaccines Under
the HPV Vaccine Development for Cervical Cancer,
Moderator: Kimberly L. Levinson, Leslie R. Boyd, MD
MD, MPH
Your Diagnosis Is
HPV Vaccine History, Moderator: Colleen K. Stockdale,
Indications, and Promising Uses MD, MS
for the Nonavalent HPV Vaccine,
Kimberly L. Levinson, MD, MPH This interactive session will test
participants knowledge regarding
Extending the Benefits of HPV vulvovaginal clinical cases,
Vaccination to the Prevention of including presentation, diagnosis,
Head and Neck Cancers, Anna R. and management.
Giuliano, PhD
Panelists:
Repurposing HPV
Vaccinations for the Prevention of Hope K. Haefner, MD
Head and Neck Cancer, Sara I. Pai, Kathryn C. Welch, MD
MD, PhD Cynthia A. Rasmussen, MD
Colposcopy Review Project ECHO
Moderator: Kathleen M. Schmeler,
Colposcopy: Tips and Tricks MD
for a Successful Practice, Barbara S.
Apgar, MD, MSc & Candice A.
Panel session and discussion
Tedeschi, NP
presenting an innovative and
Plenary #6: Beyond CDC collaborative model to impact
Coaching: HPV Vaccination cervical cancer screening and
in Populations with management of pre-invasive
Unique Barriers disease in medically underserved
Moderator: Deanna G.K. Teoh, MD, areas of Texas and internationally.
MS
Panelists:
Preventing Secondary
Malignancy: HPV Vaccination for Ellen S. Baker, MD, MPH
Pediatric, Adolescent, & Young Mila P. Salcedo, MD, PhD
Adult Cancer Survivors, Deanna Rebecca Richards-Kortum, PhD
G.K. Teoh, MD, MS Joseph Anthony Ogburn, MD
Alan G. Waxman, MD, MPH
Catch-up and Mid-Adult HPV
Kathleen M. Doughtie, DNP,
Immunization: Focus on Low
APRN, WHNP
Income and Uninsured Adults,
Sangini S. Sheth, MD, MPH
www.asccp.org/2021meeting
Register Today!
Why Attend a Virtual Meeting?
Access more content at a lower cost
Virtual meetings offer a flexible schedule with on-demand recordings
Access content from the safety and comfort of your home or office
Earn more CME credits
Early Bird Registration Ends January 31!
Become an ASCCP Member and Save on Registration
Early Bird
Regular
Registration Type Registration
Registration
(Ends January 31)
Physician Member $695 $745
Physician Non-Member $995 $1,045
Nurse/Nurse Practitioner/ Midwife Member/ $595 $645
Physician Assistant/Researcher Member
Nurse/Nurse Practitioner/ Midwife Member/ $895 $945
Physician Assistant/Researcher Non-Member
Trainee Member $295 $345
Trainee Non-Member* $395 $445
Non-Medical/Industry Consultant $1,095 $1,145
International World Bank Rate** $395 $445
* Trainees registering as non-members will be asked to provide a letter from their Department Chair confirming
residency status or a copy of their student ID card.
** International World Bank Rate: Attendees who reside in countries that are considered ‘Lower-middle’ or ‘Low’
income countries are eligible for a discounted rate.Continuing Medical Education Credits
Credit information is based on the original live program and are expected to increase.
Final number of credits available will be announced prior to the start of the meeting.
ACCME Accreditation
ASCCP is accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.
Scientific Meeting
ASCCP designates this enduring activity for maximum of 20 AMA PRA Category 1
Credits™. Physicians should claim only the credit commensurate with the extent of
their participation in the activity.
Pre-Course: Screening for Anal Disease
ASCCP designates this enduring activity for a maximum of 3.5 AMA PRA Category 1
Credits™. Physicians should claim only the redit commensurate with the extent of their
participation in the activity.
Pre-Course: Advanced Discussions in Vulvovaginal Diseases
ASCCP designates this enduring activity for maximum of 3.5 AMA PRA Category 1
Credits™. Physicians should claim only the credit commensurate with the extent of
their participation in the activity.
With new ASCCP Risk-Based Management
Consensus Guidelines, comes a
new ASCCP App!
• Simple Navigation
• Straightforward Guidance
• Easy Access
For more information, visit www.asccp.org/mobile-appImproving Lives Through the Prevention & Treatment
of Anogenital & HPV-Related Diseases
131 Rollins Ave, Suite 2, Rockville, MD 20852
ASCCP 2021 Virtual Scientific Meeting
on Anogenital & HPV-Related Diseases
Starting in April 2021You can also read
